Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.69 |
| ▸ | KDM1A | O60341 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 3/20 | 0.42 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262171 | 1.00 | BTK (0.69) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL384010 | 1.00 | BTK (0.69) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL30915791 | 1.00 | BTK (0.69) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL22050935 | 0.94 | BTK (0.80) | BTKKDM1AMAOBKMT2AGAA | |
| Formic Acid SCHEMBL27879894 | 0.94 | BTK (0.61) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL17685322 | 0.92 | BTK (0.60) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL17685323 | 0.92 | BTK (0.60) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL182101 | 0.91 | BTK (0.82) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL7486096 | 0.91 | BTK (0.82) | BTKKDM1AMAOBKMT2AGAA | |
| SCHEMBL540505 | 0.91 | BTK (0.82) | BTKKDM1AMAOBKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118703215-A | Soil conditioner for saline-alkali soil and preparation method thereof | 河北硅谷肥业有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-117756810-A | Preparation method of trans-7H-pyrrolo [2,3-d ] pyrimidine compound | 苏州莱安医药化学技术有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116874803-A | Antibacterial dendritic polyester polymer and preparation method and application thereof | 清华大学深圳国际研究生院 | 2023-10-13 | — | — | CN | claimed |
| CN-116120213-A | Synthesis method of trans-4- (tert-butoxycarbonylamino) cyclohexane carboxylic acid | 重庆医药高等专科学校 | 2023-05-16 | — | — | CN | claimed |
| CN-116082192-A | Preparation method of trans-4- (tert-butoxycarbonylamino) cyclohexane carboxylic acid | 重庆医药高等专科学校 | 2023-05-09 | — | — | CN | claimed |
| CN-113402428-B | Preparation method of trans-4- (tert-butoxycarbonylamino) cyclohexanecarboxylic acid and intermediate thereof | 重庆医药高等专科学校 | 2023-03-03 | — | — | CN | claimed |
| CN-114426504-A | Preparation method of trans- (N-4-Boc-aminocyclohexane) acetic acid | 泰州精英化成医药科技有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-111909156-B | Preparation method of olatinib maleate | 常州齐晖药业有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-112279854-B | Preparation method of 7H-pyrrolo [2,3-d ] pyrimidine compound | 常州齐晖药业有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-113402428-A | Preparation method of trans-4- (tert-butoxycarbonylamino) cyclohexanecarboxylic acid and intermediate thereof | 重庆医药高等专科学校 | 2021-09-17 | — | — | CN | claimed |
| CN-112279854-A | Preparation method of 7H-pyrrolo [2,3-d ] pyrimidine compound | 常州齐晖药业有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-111909156-A | Preparation method of olatinib maleate | 常州齐晖药业有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-105085296-B | The method that one kind prepares trans 4 (t-butoxycarbonyl amino) cyclohexanecarboxylic acid intermediate isomerization | 常州齐晖药业有限公司 | 2017-08-08 | — | — | CN | claimed |
| US-20140364490-A1 | 1-OXO/ACYLATION-14-ACYLATED ORIDONIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | HANGZHOU BENSHENG PHARMACEUTICAL CO., LTD. (CN) | 2014-12-11 | — | — | US | claimed |
| EP-2805955-A1 | 1-OXO/ACYLATION-14-ACYLATED ORIDONIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Hangzhou Bensheng Pharmaceutical Co., Ltd. (CN) | 2014-11-26 | — | — | EP | claimed |
| WO-2026104812-A1 | RAB27 INHIBITORS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-05-21 | — | — | WO | disclosed |
| EP-4734988-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF USE THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-1998025897-A1 | PIPERIDINES, PYRROLIDINES AND HEXAHYDRO-1H-AZEPINES PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1998-06-18 | — | — | WO | disclosed |
| WO-1997023508-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1997-07-03 | — | — | WO | disclosed |
| US-5215967-A | AMINOACID DERIVATIVES INHIBITING RENIN | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364490-A1 | 1-OXO/ACYLATION-14-ACYLATED ORIDONIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | FAR1, CYP51A1, GOT1 | BTK 3579/4885KDM1A 2540/4885MAOB 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.